Iliadis, Athanassios
39  results:
Search for persons X
?
1

Structural identifiability and sensitivity:

Iliadis, Athanassios
Journal of Pharmacokinetics and Pharmacodynamics.  46 (2019)  2 - p. 127-135 , 2019
 
?
2

A reaction limited in vivo dissolution model for the study ..:

Macheras, Panos ; Iliadis, Athanassios ; Melagraki, Georgia
European Journal of Pharmaceutical Sciences.  117 (2018)  - p. 98-106 , 2018
 
?
4

Revisiting dosing regimen using PK/PD modeling: the MODEL1 ..:

Hénin, Emilie ; Meille, Christophe ; Barbolosi, Dominique...
Breast Cancer Research and Treatment.  156 (2016)  2 - p. 331-341 , 2016
 
?
5

Model-based assessment of erlotinib effect in vitro measure..:

Benay, Stephan ; Meille, Christophe ; Kustermann, Stefan...
Journal of Pharmacokinetics and Pharmacodynamics.  42 (2015)  3 - p. 275-285 , 2015
 
?
7

Physiologically based pharmacokinetic modeling of CYP3A4 in..:

Baneyx, Guillaume ; Parrott, Neil ; Meille, Christophe..
European Journal of Pharmaceutical Sciences.  56 (2014)  - p. 1-15 , 2014
 
?
11

Positive interaction between lapatinib and capecitabine in ..:

Chefrour, Mohamed ; Milano, Gérard ; Formento, Patricia...
Fundamental & Clinical Pharmacology.  26 (2011)  4 - p. 530-537 , 2011
 
?
12

Early severe toxicities after capecitabine intake: possible..:

Mercier, Cedric ; Dupuis, Charlotte ; Blesius, Aurore...
Cancer Chemotherapy and Pharmacology.  63 (2008)  6 - p. 1177-1180 , 2008
 
?
14

Optimizing Drug Regimens in Cancer Chemotherapy:

Iliadis, Athanassios
Basic & Clinical Pharmacology & Toxicology.  96 (2005)  3 - p. 269-270 , 2005
 
1-15